FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Phosphate Injection
Status: Currently in Shortage
»Date first posted: 04/14/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology

Expand all

Fresenius Kabi USA, LLC (Revised 07/14/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 15 mmol per 5 mL, Potassium 22 mEq per 5 mL,single dose vial (NDC 63323-086-05) Available Check wholesalers for inventory Demand increase for the drug
Phosphorus 45 mmol per 15 mL, Potassium 66 mEq per 15 mL, single dose vial (NDC 63323-086-15) Backordered. Next release anticipated August 2017. Check wholesalers for inventory Demand increase for the drug
Phosphorus 150 mmol per 50 mL, Potassium 220 mEq per 50 mL, single dose vial (NDC 63323-086-50) Backordered. Next release anticipated August 2017. Check wholesalers for inventory Demand increase for the drug

Hospira, Inc. (Revised 07/07/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3 mM P/ml; 45 mM P/15 mL Single Dose Glass Fliptop Vial (NDC 00409-7295-01) Next delivery: Late July 2017; Estimated recovery: September 2017 Shortage per manufacturer: Manufacturing Delay. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English